Organigram Secures Supply Agreement With Medical Cannabis by Shoppers
16 January 2020 - 10:00PM
Business Wire
Agreement highlights Company’s strong
commitment to Canada’s medical cannabis community
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent
company of Organigram Inc. (the “Company” or “Organigram”), a
leading licensed producer of cannabis, is pleased to announce it
has secured a supply agreement with Medical Cannabis by Shoppers,
the online medical cannabis platform by Shoppers Drug Mart Inc.
(“Shoppers”).
This agreement reflects the companies’ shared commitment to
offering Canadian consumers access to high quality medical cannabis
products.
“We are extremely proud to partner with Shoppers and believe
that our complementary approach to the medical cannabis market will
offer the full strength of our combined national networks to
Canadian patients,” says Tim Emberg, Senior Vice President of Sales
and Commercial Operations. “We are pleased that we will now be able
to offer medical cannabis patients across the country even greater
access to our growing portfolio of high-quality products.”
Under the terms of the agreement, Organigram will provide
Shoppers with a wide range of products including dried flower, oils
and other future derivative products as they become available. The
agreement is for a three-year term subject to renewal for an
additional two years.
“Since our inception, patients have been an important priority
for our team,” says Greg Engel, CEO, Organigram. “We want patients
to feel supported and to know that we are working on developing
products, technology and partnerships with their best interests in
mind.”
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select and TSX
listed company whose wholly owned subsidiary, Organigram Inc., is a
licensed producer of cannabis and cannabis-derived products in
Canada.
Organigram is focused on producing high-quality, indoor-grown
cannabis for patients and adult recreational consumers in Canada,
as well as developing international business partnerships to extend
the Company's global footprint. Organigram has also developed a
portfolio of legal adult use recreational cannabis brands including
The Edison Cannabis Company, Ankr Organics and Trailblazer.
Organigram's primary facility is located in Moncton, New Brunswick
and the Company is regulated by the Cannabis Act and the Cannabis
Regulations (Canada).
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “expects”, “estimates”,
“intends”, “anticipates”, “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information including
risks as disclosed in the Company’s most recent annual information
form, management’s discussion and analysis and other Company
documents filed from time to time on SEDAR (see www.sedar.com) and
filed or furnished to the Securities and Exchange Commission on
EDGAR (see www.sec.gov). Readers are cautioned not to place undue
reliance on these forward-looking statements, which speak only as
of the date of this press release. Although the Company believes
that the assumptions and factors used in preparing the
forward-looking information in this news release are reasonable,
undue reliance should not be placed on such information and no
assurance can be given that such events will occur in the disclosed
time frames or at all. The forward-looking information included in
this news release are made as of the date of this news release and
the Company disclaims any intention or obligation, except to the
extent required by law, to update or revise any forward-looking
information, whether as a result of new information, future events
or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200116005198/en/
For Investor Relations enquiries: Amy Schwalm Vice President,
Investor Relations Amy.Schwalm@organigram.ca (416) 704-9057
For Media enquiries: Ray Gracewood Senior Vice President,
Marketing and Communications ray.gracewood@organigram.ca (506)
645-1653
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Apr 2024 to May 2024
Organigram (NASDAQ:OGI)
Historical Stock Chart
From May 2023 to May 2024